IBDEI0DR ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34502,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,34502,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,34503,0)
 ;;=C90.30^^105^1433^202
 ;;^UTILITY(U,$J,358.3,34503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34503,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,34503,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,34503,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,34504,0)
 ;;=D56.3^^105^1433^203
 ;;^UTILITY(U,$J,358.3,34504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34504,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,34504,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,34504,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,34505,0)
 ;;=D56.9^^105^1433^204
 ;;^UTILITY(U,$J,358.3,34505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34505,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,34505,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,34505,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,34506,0)
 ;;=D51.2^^105^1433^207
 ;;^UTILITY(U,$J,358.3,34506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34506,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,34506,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,34506,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,34507,0)
 ;;=D05.92^^105^1433^40
 ;;^UTILITY(U,$J,358.3,34507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34507,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,34507,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,34507,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,34508,0)
 ;;=D05.91^^105^1433^42
 ;;^UTILITY(U,$J,358.3,34508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34508,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,34508,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,34508,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,34509,0)
 ;;=D05.90^^105^1433^38
 ;;^UTILITY(U,$J,358.3,34509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34509,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,34509,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,34509,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,34510,0)
 ;;=D51.0^^105^1433^208
 ;;^UTILITY(U,$J,358.3,34510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34510,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,34510,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,34510,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,34511,0)
 ;;=D51.1^^105^1433^209
 ;;^UTILITY(U,$J,358.3,34511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34511,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,34511,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,34511,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,34512,0)
 ;;=D51.9^^105^1433^211
 ;;^UTILITY(U,$J,358.3,34512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34512,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34512,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,34512,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,34513,0)
 ;;=D68.0^^105^1433^213
 ;;^UTILITY(U,$J,358.3,34513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34513,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,34513,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,34513,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,34514,0)
 ;;=C88.0^^105^1433^214
 ;;^UTILITY(U,$J,358.3,34514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34514,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,34514,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,34514,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,34515,0)
 ;;=C91.02^^105^1433^3
 ;;^UTILITY(U,$J,358.3,34515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34515,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,34515,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,34515,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,34516,0)
 ;;=C92.02^^105^1433^6
 ;;^UTILITY(U,$J,358.3,34516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34516,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,34516,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,34516,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,34517,0)
 ;;=D09.3^^105^1433^50
 ;;^UTILITY(U,$J,358.3,34517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34517,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,34517,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,34517,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,34518,0)
 ;;=C22.0^^105^1433^91
 ;;^UTILITY(U,$J,358.3,34518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34518,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,34518,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,34518,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,34519,0)
 ;;=C24.9^^105^1433^118
 ;;^UTILITY(U,$J,358.3,34519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34519,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,34519,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,34519,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,34520,0)
 ;;=C50.922^^105^1433^142
 ;;^UTILITY(U,$J,358.3,34520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34520,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,34520,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,34520,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,34521,0)
 ;;=C34.91^^105^1433^160
 ;;^UTILITY(U,$J,358.3,34521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34521,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,34521,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,34521,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,34522,0)
 ;;=C50.921^^105^1433^164
 ;;^UTILITY(U,$J,358.3,34522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34522,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,34522,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,34522,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,34523,0)
 ;;=C90.02^^105^1433^176
 ;;^UTILITY(U,$J,358.3,34523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34523,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,34523,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,34523,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,34524,0)
 ;;=D51.9^^105^1433^25
 ;;^UTILITY(U,$J,358.3,34524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34524,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,34524,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,34524,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,34525,0)
 ;;=C79.51^^105^1433^35
 ;;^UTILITY(U,$J,358.3,34525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34525,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,34525,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,34525,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,34526,0)
 ;;=C80.1^^105^1433^171
 ;;^UTILITY(U,$J,358.3,34526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34526,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
 ;;^UTILITY(U,$J,358.3,34526,1,4,0)
 ;;=4^C80.1
 ;;^UTILITY(U,$J,358.3,34526,2)
 ;;=^5001389
 ;;^UTILITY(U,$J,358.3,34527,0)
 ;;=C80.0^^105^1433^172
 ;;^UTILITY(U,$J,358.3,34527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34527,1,3,0)
 ;;=3^Malig Neop,Unspec Primary or Secondary
 ;;^UTILITY(U,$J,358.3,34527,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,34527,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,34528,0)
 ;;=E28.39^^105^1433^96
 ;;^UTILITY(U,$J,358.3,34528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34528,1,3,0)
 ;;=3^Hypogonadism,Ovarian
 ;;^UTILITY(U,$J,358.3,34528,1,4,0)
 ;;=4^E28.39
 ;;^UTILITY(U,$J,358.3,34528,2)
 ;;=^5002752
 ;;^UTILITY(U,$J,358.3,34529,0)
 ;;=E29.1^^105^1433^97
 ;;^UTILITY(U,$J,358.3,34529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34529,1,3,0)
 ;;=3^Hypogonadism,Testicular
 ;;^UTILITY(U,$J,358.3,34529,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,34529,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,34530,0)
 ;;=C96.20^^105^1433^111
 ;;^UTILITY(U,$J,358.3,34530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34530,1,3,0)
 ;;=3^Malig Mast Cell Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,34530,1,4,0)
 ;;=4^C96.20
 ;;^UTILITY(U,$J,358.3,34530,2)
 ;;=^5151293
 ;;^UTILITY(U,$J,358.3,34531,0)
 ;;=C96.22^^105^1433^173
 ;;^UTILITY(U,$J,358.3,34531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34531,1,3,0)
 ;;=3^Mast Cell Sarcoma
 ;;^UTILITY(U,$J,358.3,34531,1,4,0)
 ;;=4^C96.22
 ;;^UTILITY(U,$J,358.3,34531,2)
 ;;=^5151295
 ;;^UTILITY(U,$J,358.3,34532,0)
 ;;=D64.9^^105^1433^26
 ;;^UTILITY(U,$J,358.3,34532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34532,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34532,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,34532,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,34533,0)
 ;;=D59.10^^105^1433^32
 ;;^UTILITY(U,$J,358.3,34533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34533,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34533,1,4,0)
 ;;=4^D59.10
 ;;^UTILITY(U,$J,358.3,34533,2)
 ;;=^5159101
 ;;^UTILITY(U,$J,358.3,34534,0)
 ;;=D59.11^^105^1433^33
 ;;^UTILITY(U,$J,358.3,34534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34534,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Warm
 ;;^UTILITY(U,$J,358.3,34534,1,4,0)
 ;;=4^D59.11
 ;;^UTILITY(U,$J,358.3,34534,2)
 ;;=^5159102
 ;;^UTILITY(U,$J,358.3,34535,0)
 ;;=D59.12^^105^1433^29
 ;;^UTILITY(U,$J,358.3,34535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34535,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Cold
 ;;^UTILITY(U,$J,358.3,34535,1,4,0)
 ;;=4^D59.12
 ;;^UTILITY(U,$J,358.3,34535,2)
 ;;=^5159103
 ;;^UTILITY(U,$J,358.3,34536,0)
 ;;=D59.13^^105^1433^30
 ;;^UTILITY(U,$J,358.3,34536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34536,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Mixed Type
 ;;^UTILITY(U,$J,358.3,34536,1,4,0)
 ;;=4^D59.13
 ;;^UTILITY(U,$J,358.3,34536,2)
 ;;=^5159104
 ;;^UTILITY(U,$J,358.3,34537,0)
 ;;=D59.19^^105^1433^31
 ;;^UTILITY(U,$J,358.3,34537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34537,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,34537,1,4,0)
 ;;=4^D59.19
 ;;^UTILITY(U,$J,358.3,34537,2)
 ;;=^5159105
 ;;^UTILITY(U,$J,358.3,34538,0)
 ;;=D57.20^^105^1433^201
 ;;^UTILITY(U,$J,358.3,34538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34538,1,3,0)
 ;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,34538,1,4,0)
 ;;=4^D57.20
 ;;^UTILITY(U,$J,358.3,34538,2)
 ;;=^330080
 ;;^UTILITY(U,$J,358.3,34539,0)
 ;;=D57.211^^105^1433^196
 ;;^UTILITY(U,$J,358.3,34539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34539,1,3,0)
 ;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
 ;;^UTILITY(U,$J,358.3,34539,1,4,0)
 ;;=4^D57.211
 ;;^UTILITY(U,$J,358.3,34539,2)
 ;;=^5002310
 ;;^UTILITY(U,$J,358.3,34540,0)
 ;;=D57.212^^105^1433^200
 ;;^UTILITY(U,$J,358.3,34540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34540,1,3,0)
 ;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,34540,1,4,0)
 ;;=4^D57.212
 ;;^UTILITY(U,$J,358.3,34540,2)
 ;;=^5002311
 ;;^UTILITY(U,$J,358.3,34541,0)
 ;;=D57.213^^105^1433^197
 ;;^UTILITY(U,$J,358.3,34541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34541,1,3,0)
 ;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
 ;;^UTILITY(U,$J,358.3,34541,1,4,0)
 ;;=4^D57.213
 ;;^UTILITY(U,$J,358.3,34541,2)
 ;;=^5159080
 ;;^UTILITY(U,$J,358.3,34542,0)
 ;;=D57.218^^105^1433^198
 ;;^UTILITY(U,$J,358.3,34542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34542,1,3,0)
 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
 ;;^UTILITY(U,$J,358.3,34542,1,4,0)
 ;;=4^D57.218
 ;;^UTILITY(U,$J,358.3,34542,2)
 ;;=^5159081
 ;;^UTILITY(U,$J,358.3,34543,0)
 ;;=D57.219^^105^1433^199
 ;;^UTILITY(U,$J,358.3,34543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34543,1,3,0)
 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,34543,1,4,0)
 ;;=4^D57.219
 ;;^UTILITY(U,$J,358.3,34543,2)
 ;;=^5002312
 ;;^UTILITY(U,$J,358.3,34544,0)
 ;;=D57.3^^105^1433^195
 ;;^UTILITY(U,$J,358.3,34544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34544,1,3,0)
 ;;=3^Sickle-Cell Trait
 ;;^UTILITY(U,$J,358.3,34544,1,4,0)
 ;;=4^D57.3
 ;;^UTILITY(U,$J,358.3,34544,2)
 ;;=^5002313
 ;;^UTILITY(U,$J,358.3,34545,0)
 ;;=D57.40^^105^1433^192
 ;;^UTILITY(U,$J,358.3,34545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34545,1,3,0)
 ;;=3^Sickle-Cell Thalassemia w/o Crisis
 ;;^UTILITY(U,$J,358.3,34545,1,4,0)
 ;;=4^D57.40
 ;;^UTILITY(U,$J,358.3,34545,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,34546,0)
 ;;=D57.411^^105^1433^193
 ;;^UTILITY(U,$J,358.3,34546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34546,1,3,0)
 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
 ;;^UTILITY(U,$J,358.3,34546,1,4,0)
 ;;=4^D57.411
 ;;^UTILITY(U,$J,358.3,34546,2)
 ;;=^5002314
 ;;^UTILITY(U,$J,358.3,34547,0)
 ;;=D57.412^^105^1433^194
 ;;^UTILITY(U,$J,358.3,34547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34547,1,3,0)
 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,34547,1,4,0)
 ;;=4^D57.412
 ;;^UTILITY(U,$J,358.3,34547,2)
 ;;=^5002315
 ;;^UTILITY(U,$J,358.3,34548,0)
 ;;=M31.10^^105^1433^215
 ;;^UTILITY(U,$J,358.3,34548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34548,1,3,0)
 ;;=3^Thrombotic Microangiopathy,Unspec
 ;;^UTILITY(U,$J,358.3,34548,1,4,0)
 ;;=4^M31.10
 ;;^UTILITY(U,$J,358.3,34548,2)
 ;;=^5161189
 ;;^UTILITY(U,$J,358.3,34549,0)
 ;;=Z85.818^^105^1434^86
 ;;^UTILITY(U,$J,358.3,34549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34549,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
 ;;^UTILITY(U,$J,358.3,34549,1,4,0)
 ;;=4^Z85.818
 ;;^UTILITY(U,$J,358.3,34549,2)
 ;;=^5063439
 ;;^UTILITY(U,$J,358.3,34550,0)
 ;;=Z85.819^^105^1434^87
 ;;^UTILITY(U,$J,358.3,34550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34550,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx,Unspec
 ;;^UTILITY(U,$J,358.3,34550,1,4,0)
 ;;=4^Z85.819
 ;;^UTILITY(U,$J,358.3,34550,2)
 ;;=^5063440
 ;;^UTILITY(U,$J,358.3,34551,0)
 ;;=Z85.01^^105^1434^82
 ;;^UTILITY(U,$J,358.3,34551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34551,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Esophagus
 ;;^UTILITY(U,$J,358.3,34551,1,4,0)
 ;;=4^Z85.01
 ;;^UTILITY(U,$J,358.3,34551,2)
 ;;=^5063395
 ;;^UTILITY(U,$J,358.3,34552,0)
 ;;=Z85.028^^105^1434^93
 ;;^UTILITY(U,$J,358.3,34552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34552,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Stomach
 ;;^UTILITY(U,$J,358.3,34552,1,4,0)
 ;;=4^Z85.028
 ;;^UTILITY(U,$J,358.3,34552,2)
 ;;=^5063397
 ;;^UTILITY(U,$J,358.3,34553,0)
 ;;=Z85.038^^105^1434^84
 ;;^UTILITY(U,$J,358.3,34553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34553,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Large Intestine
 ;;^UTILITY(U,$J,358.3,34553,1,4,0)
 ;;=4^Z85.038
 ;;^UTILITY(U,$J,358.3,34553,2)
 ;;=^5063399
 ;;^UTILITY(U,$J,358.3,34554,0)
 ;;=Z85.048^^105^1434^91
 ;;^UTILITY(U,$J,358.3,34554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34554,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Rectum,Rectosig Junct & Anus
 ;;^UTILITY(U,$J,358.3,34554,1,4,0)
 ;;=4^Z85.048
 ;;^UTILITY(U,$J,358.3,34554,2)
 ;;=^5063401
 ;;^UTILITY(U,$J,358.3,34555,0)
 ;;=Z85.118^^105^1434^80
 ;;^UTILITY(U,$J,358.3,34555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34555,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bronchus & Lung
 ;;^UTILITY(U,$J,358.3,34555,1,4,0)
 ;;=4^Z85.118
 ;;^UTILITY(U,$J,358.3,34555,2)
 ;;=^5063408
 ;;^UTILITY(U,$J,358.3,34556,0)
 ;;=Z85.21^^105^1434^85
 ;;^UTILITY(U,$J,358.3,34556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34556,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Larynx
 ;;^UTILITY(U,$J,358.3,34556,1,4,0)
 ;;=4^Z85.21
 ;;^UTILITY(U,$J,358.3,34556,2)
 ;;=^5063411
 ;;^UTILITY(U,$J,358.3,34557,0)
 ;;=Z85.3^^105^1434^79
 ;;^UTILITY(U,$J,358.3,34557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34557,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,34557,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,34557,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,34558,0)
 ;;=Z85.41^^105^1434^81
 ;;^UTILITY(U,$J,358.3,34558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34558,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,34558,1,4,0)
 ;;=4^Z85.41
 ;;^UTILITY(U,$J,358.3,34558,2)
 ;;=^5063418
 ;;^UTILITY(U,$J,358.3,34559,0)
 ;;=Z85.43^^105^1434^89
 ;;^UTILITY(U,$J,358.3,34559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34559,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,34559,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,34559,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,34560,0)
 ;;=Z85.46^^105^1434^90
 ;;^UTILITY(U,$J,358.3,34560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34560,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,34560,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,34560,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,34561,0)
 ;;=Z85.47^^105^1434^94
 ;;^UTILITY(U,$J,358.3,34561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34561,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,34561,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,34561,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,34562,0)
 ;;=Z85.51^^105^1434^78
 ;;^UTILITY(U,$J,358.3,34562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34562,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bladder
 ;;^UTILITY(U,$J,358.3,34562,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,34562,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,34563,0)
 ;;=Z85.528^^105^1434^83
 ;;^UTILITY(U,$J,358.3,34563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34563,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,34563,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,34563,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,34564,0)
 ;;=Z85.6^^105^1434^74
 ;;^UTILITY(U,$J,358.3,34564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34564,1,3,0)
 ;;=3^Personal Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,34564,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,34564,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,34565,0)
 ;;=Z85.72^^105^1434^98
 ;;^UTILITY(U,$J,358.3,34565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34565,1,3,0)
 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
 ;;^UTILITY(U,$J,358.3,34565,1,4,0)
 ;;=4^Z85.72
 ;;^UTILITY(U,$J,358.3,34565,2)
 ;;=^5063436
 ;;^UTILITY(U,$J,358.3,34566,0)
 ;;=Z85.79^^105^1434^88
 ;;^UTILITY(U,$J,358.3,34566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34566,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
 ;;^UTILITY(U,$J,358.3,34566,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,34566,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,34567,0)
 ;;=Z85.820^^105^1434^77
 ;;^UTILITY(U,$J,358.3,34567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34567,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,34567,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,34567,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,34568,0)
 ;;=Z85.828^^105^1434^92
 ;;^UTILITY(U,$J,358.3,34568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34568,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,34568,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,34568,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,34569,0)
 ;;=Z85.71^^105^1434^72
 ;;^UTILITY(U,$J,358.3,34569,1,0)
 ;;=^358.31IA^4^2
